Published in
Oxford University Press (OUP), The Journal of Infectious Diseases, 7(201), p. 1054-1062
DOI: 10.1086/651168
Links
- ORCID
- Oxford University Press (OUP) | PDF
- [edoc.unibas.ch]
- [dx.doi.org] | PDF
- [www.zora.uzh.ch] | PDF
- [doc.rero.ch] | PDF
- [www.researchgate.net] | PDF
- [www.zora.uzh.ch] | PDF
Tools
Epidemiological and biological evidence for a compensatory effect of connection domain mutation N348I on M184V in HIV-1 reverse transcriptase
Journal article published in 2010 by
Viktor von Wyl,
Maryam Ehteshami,
Jori Symons 
,
Monique Nijhuis,
Philippe Bürgisser,
Lisa M. Demeter,
Sabine Yerly,
Jürg Böni,
Rob Schuurman,
Matthias Götte,
Huldrych F F. Günthard,
Thomas Klimkait,
Bruno Ledergerber,
F. Günthard Huldrych,
Swiss Hiv Cohort Study
and other authors.
,
Monique Nijhuis,
Philippe Bürgisser,
Lisa M. Demeter,
Sabine Yerly,
Jürg Böni,
Rob Schuurman,
Matthias Götte,
Huldrych F F. Günthard,
Thomas Klimkait,
Bruno Ledergerber,
F. Günthard Huldrych,
Swiss Hiv Cohort Study
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
The connection domain mutation N348I confers resistance to zidovudine (AZT) and is associated with the lamivudine (3TC) mutation M184V. We explored the biochemical and virological influence of N348I in the context of M184V.